Core Insights - LifeMD, Inc. has sold its majority ownership interest in WorkSimpli Software LLC for an enterprise value of approximately $65 million, marking a strategic shift towards focusing on virtual healthcare and pharmacy services [1][4] - The transaction closed on November 4, 2025, with LifeMD receiving about $22 million in cash at closing, which is 91.6% of the base purchase price for the 80% interest sold [2][3] Financial Details - LifeMD is eligible to receive up to an additional $28 million in cash based on WorkSimpli achieving specific growth and operational targets over the next three years [3] - The initial investment by LifeMD in WorkSimpli was approximately $1.25 million, with a 73.3% ownership prior to the sale [4] Strategic Focus - Following the divestiture, LifeMD will concentrate on expanding its virtual care and pharmacy offerings, particularly in areas such as weight management, women's health, behavioral health, urgent care, and primary care [5] - LifeMD plans to broaden its platform into more complex cardiometabolic care offerings starting in the first half of 2026 [5] Leadership Commentary - LifeMD's CEO emphasized that the divestiture allows the company to sharpen its focus on building a comprehensive virtual care technology platform [4] - WorkSimpli's CEO expressed excitement about the independence gained from the transaction, which will enable further investment in their products and services [5]